Vir Biotechnology, Inc. (VIR)

NASDAQ: VIR · USD

$11.9

+0.37 (+3.2%)· Recorded snapshot

Market cap	2B
Revenue (ttm)	303.2M
Net income (ttm)	-251.7M
EPS (ttm)	-$1.70
Shares out	169.2M
Volume	1,257,830
Beta	1.59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 303.2M
Net income (ttm): -251.7M
EPS (ttm): -$1.70
Market cap: 2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-26.1

P25 n/aP50 n/aP75 n/a

ROIC-57.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIR indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001706431
Company name	Vir Biotechnology, Inc.
Country	United States
Country code	US
CUSIP number	92764N102
Earnings date	2026-11-04
Earnings time	amc
Employees	367
Employees change	-41
Employees growth	-10.05%
Enterprise value	$1.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2019-10-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US92764N1028
Last 10-K release date	2026-02-23
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2B
Market cap category	Small-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$11.94
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	VIR
U.S. state	California
Website	https://www.vir.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.22%
EV/Sales	5.09x
FCF / EV yield	-13.2%
FCF yield	-10.27%
Forward EV/Sales	28.78x
Forward P/S	36.98x
P/B ratio	1.99x
P/S ratio	6.54x
Price / tangible book value	2.07x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-92.16%
EBITDA margin	-88.37%
Gross margin	-59.39%
Operating margin	-92.16%
Pretax margin	-82.87%
Profit margin	-83%
Profit per employee	$-685,774
Profitable quarters	1
Revenue per employee	$826,232
ROA	-14.51%
ROA (5Y)	-4.38%
ROCE	-24.96%
ROE	-26.08%
ROE (5Y)	-7.75%
ROIC	-57.32%
SBC / revenue	15.51%
Tax / revenue	0.13%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	5
EPS growth years	2
Net income growth quarters	1
Net income growth years	2
Revenue growth	1,495.93%
Revenue growth (Q)	19,582.54%
Revenue growth 3Y	-14.83%
Revenue growth 5Y	10.66%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.1M
Depreciation and amortization	$11.5M
EBIT	$-279.5M
EBITDA	$-268M
EPS	$-1.70
FCF per share	$-1.20
Financing cash flow	$242M
Free cash flow	$-203.6M
Free cash flow minus SBC	$-250.6M
Gross profit	$-180.1M
Income taxes	$380,000
Investing cash flow	$-58.2M
Net cash flow	$-18.7M
Net income	$-251.7M
Operating cash flow minus SBC	$-249.5M
Operating income	$-279.5M
Revenue	$303.2M
Stock-based compensation	$47M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.29
Book value per share	$5.81
Debt / equity	0.09
Goodwill	$16.9M
Long-term assets	$641.1M
Long-term liabilities	$137.4M
Net cash (debt)	$439.5M
Net cash / market cap	22.17%
Net cash growth	-12.77%
Net debt / equity	-0.45
Piotroski F-Score	3
Property, plant and equipment	$109.8M
Shareholders' equity	$982.5M
Tangible book value	$957.9M
Tangible book value per share	$5.66
Total assets	$1.2B
Total cash	$532.7M
Total debt	$93.3M
Total liabilities	$232.3M
WACC	12.43%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.25
Current assets	$573.7M
Current liabilities	$95M
Current ratio	6.04
Net working capital	$-44.8M
Quick ratio	5.67
Working capital	$478.8M
Working capital turnover	0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-8.01%
Dividend yield	0%
Shareholder yield	-8.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$9.90
1D price change	3.2%
1M price change	10.51%
1M total return	10.51%
1W price change	9.68%
1W total return	9.68%
1Y price change	90.31%
1Y return CAGR	90.39%
1Y total return	90.31%
20-day SMA	$10.99
200-day SMA	$9.47
3M price change	33.86%
3M total return	33.86%
3Y price change	51.8%
3Y return CAGR	14.93%
3Y total return	51.8%
50-day SMA	$10.86
50-day SMA vs 200-day SMA	50over200
52-week high	$12.00
52-week high date	2026-10-09
52-week low	$4.82
52-week low date	2025-11-07
5Y price change	-69.91%
5Y return CAGR	-21.36%
5Y total return	-69.91%
6M price change	10.71%
6M total return	10.71%
All-time high	$141.01
All-time high date	2021-01-27
All-time low	$4.16
All-time low date	2025-08-11
Average true range (ATR)	$0.62
Average volume	1.9M
Beta (1Y)	1.44
Beta (2Y)	0.74
Beta (5Y)	1.59
Change from 52-week high	-0.5%
Change from 52-week low	147.98%
Change from all-time high	-91.65%
Change from all-time low	183.51%
Change from open	4.83%
Day's gap	-1.56%
Dollar volume	$15M
High price	$11.94
Low price	$11.39
Monthly RSI	56.76
Open price	$11.39
Position in 52-week range	100%
Premarket change	-1.38%
Premarket close	$11.57
Premarket price	$11.41
Premarket volume	2.2K
Previous close	$11.57
Price vs 150-day SMA	19.04%
Price vs 20-day SMA	7.17%
Price vs 200-day SMA	24.39%
Price vs 50-day SMA	8.48%
Relative volume	0.65
Return from IPO open	-27.46%
Return from IPO price	-41.43%
RSI	61.07
Sharpe ratio	1.25
Sharpe ratio (3Y)	0.45
Sharpe ratio (5Y)	-0.04
Sortino ratio	2.24
Sortino ratio (3Y)	0.89
Sortino ratio (5Y)	0.02
Volume	1.3M
Weekly RSI	61.72
YTD price change	95.36%
YTD total return	95.36%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	129.8M
Float percentage	76.72%
Shares change (QoQ)	14.61%
Shares change (YoY)	8.01%
Shares held by insiders	4.23%
Shares held by institutions	70.19%
Shares outstanding	169.2M
Short % of float	11.54%
Short % of shares	8.85%
Short ratio	6.9 days

Deeper analysis on VIR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIR report

Is a complete VIR research report available?

No complete published report is available for Vir Biotechnology, Inc. (VIR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Vir Biotechnology, Inc. (VIR)

Price

Financial snapshot

Fair-value bridge

Latest news · VIR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIR

Frequently asked questions